Date: April 12, 2021 

Source: College of Chemistry and Material Science

Prof. Chen Tianfeng's team in JNU's College of Chemistry and Material Science published a paper titled Selenium nanoparticles regulates selenoprotein to boostcytokine-induced killer cells-based cancer immunotherapy in Nano Today (IF=16.903) in October. 

This research was funded by the National Natural Science Foundation of China. JNU is the paper's sole completing unit. Liu Ting, a postdoctoral researcher at the First Affiliated Hospital of JNU, is the first author, and Prof. Xu Ligeng is the co-first author. Chen is the corresponding author. 

Chen's team is dedicated to applied research in innovative tumor target chemical drugs and multimodal precise diagnosis. The team has been funded by the young talents sub-projects of the 10,000 Talents Program, the National High-Tech Research and Development Program (863 Program) and the National Natural Science Foundation of China.

Link to paper: 

https://www.sciencedirect.com/science/article/pii/S1748013220301444